Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Assessing the toxicity and associated costs among pediatric patients admitted with unintentional poisonings of attention-deficit/hyperactivity disorder drugs in the United States.

Levine M, Froberg B, Ruha AM, Burns-Ewald M, Yen M, Claudius IA, Arthur AO, Tormoehlen L, Thomas SH.

Clin Toxicol (Phila). 2013 Mar;51(3):147-50. doi: 10.3109/15563650.2013.772623.

PMID:
23473458
2.

Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.

Winterstein AG, Gerhard T, Shuster J, Zito J, Johnson M, Liu H, Saidi A.

Ann Pharmacother. 2008 Jan;42(1):24-31. Epub 2007 Nov 27.

PMID:
18042808
3.

Emergency department use and costs for youth with attention-deficit/hyperactivity disorder: associations with stimulant treatment.

Leibson CL, Barbaresi WJ, Ransom J, Colligan RC, Kemner J, Weaver AL, Katusic SK.

Ambul Pediatr. 2006 Jan-Feb;6(1):45-53.

PMID:
16443183
4.

Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States.

Doshi JA, Hodgkins P, Kahle J, Sikirica V, Cangelosi MJ, Setyawan J, Erder MH, Neumann PJ.

J Am Acad Child Adolesc Psychiatry. 2012 Oct;51(10):990-1002.e2. doi: 10.1016/j.jaac.2012.07.008. Epub 2012 Sep 5. Review.

PMID:
23021476
5.

ADHD medication use, adherence, persistence and cost among Texas Medicaid children.

Barner JC, Khoza S, Oladapo A.

Curr Med Res Opin. 2011;27 Suppl 2:13-22. doi: 10.1185/03007995.2011.603303.

PMID:
21973228
6.

National estimates of the inpatient burden of pediatric bipolar disorder in the United States.

Berry EA, Heaton PT, Kelton CM.

J Ment Health Policy Econ. 2011 Sep;14(3):115-23.

PMID:
22116169
7.

Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.

Power TJ, Mautone JA, Manz PH, Frye L, Blum NJ.

Pediatrics. 2008 Jan;121(1):e65-72. doi: 10.1542/peds.2007-0383.

PMID:
18166546
8.
9.

Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate.

Treceño C, Martín Arias LH, Sáinz M, Salado I, García Ortega P, Velasco V, Jimeno N, Escudero A, Velasco A, Carvajal A.

Pharmacoepidemiol Drug Saf. 2012 Apr;21(4):435-41. doi: 10.1002/pds.2348. Epub 2012 Jan 17.

PMID:
22253017
10.

Costs of attention deficit-hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000.

Birnbaum HG, Kessler RC, Lowe SW, Secnik K, Greenberg PE, Leong SA, Swensen AR.

Curr Med Res Opin. 2005 Feb;21(2):195-206.

PMID:
15801990
11.

Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.

Zito JM, Safer DJ, dosReis S, Magder LS, Gardner JF, Zarin DA.

Arch Pediatr Adolesc Med. 1999 Dec;153(12):1257-63.

PMID:
10591302
12.

Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children --- United States, 2003 and 2007.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2010 Nov 12;59(44):1439-43.

13.

Health care supply and county-level variation in attention-deficit hyperactivity disorder prescription medications.

Bruckner TA, Hodgson A, Mahoney CB, Fulton BD, Levine P, Scheffler RM.

Pharmacoepidemiol Drug Saf. 2012 Apr;21(4):442-9. doi: 10.1002/pds.2264. Epub 2011 Oct 24.

PMID:
22021031
14.

Second opinions improve ADHD prescribing in a medicaid-insured community population.

Thompson JN, Varley CK, McClellan J, Hilt R, Lee T, Kwan AC, Lee T, Trupin E.

J Am Acad Child Adolesc Psychiatry. 2009 Jul;48(7):740-8. doi: 10.1097/CHI.0b013e3181a2b2ed.

PMID:
19465882
15.

Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations.

Molife C, Bernauer MJ, Farr AM, Haynes VS, Kelsey D.

Postgrad Med. 2012 Sep;124(5):7-22. doi: 10.3810/pgm.2012.09.2586.

PMID:
23095422
16.

Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.

Guevara J, Lozano P, Wickizer T, Mell L, Gephart H.

Pediatrics. 2002 May;109(5):733-9.

PMID:
11986429
17.

Incidence of pediatric traumatic brain injury and associated hospital resource utilization in the United States.

Schneier AJ, Shields BJ, Hostetler SG, Xiang H, Smith GA.

Pediatrics. 2006 Aug;118(2):483-92.

PMID:
16882799
18.

Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysis.

Marchetti A, Magar R, Lau H, Murphy EL, Jensen PS, Conners CK, Findling R, Wineburg E, Carotenuto I, Einarson TR, Iskedjian M.

Clin Ther. 2001 Nov;23(11):1904-21.

PMID:
11768842
19.
20.

Supplemental Content

Support Center